| Literature DB >> 16923519 |
Funda Erkasar Citak1, Ustun Ezer, Emel Akkaya, Nilgun Ozbulbul, Muhterem Bahce, Ahmet Emin Kurekci.
Abstract
Anthracyclin-based regimens and all-transretinoic acid (ATRA, tretinoin) as differentiating agent are commonly utilized for the treatment of acute promylelocytic leukemia (APL). There are many adverse effects that may be seen during the use of ATRA in patients with APL. Of these, ATRA-induced myositis is rarely described in adults and rare in the children with APL. Herein, we report an 11-year-old girl with APL who developed ATRA-induced myositis during induction treatment.Entities:
Mesh：
Substances：
Year: 2006 PMID： 16923519
Source DB: PubMed Journal: Haematologica ISSN： 0390-6078 Impact factor: 9.941